Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 USD | +0.71% | +0.71% | +33.02% |
Business Summary
Number of employees: 16
Managers
Managers | Title | Age | Since |
---|---|---|---|
Angelos Stergiou
FOU | Founder | 48 | 06-04-02 |
John Burns
DFI | Director of Finance/CFO | 39 | 13-04-30 |
Andrew Elnatan
LAW | General Counsel | - | 23-01-04 |
Dragan Cicic
PRN | Corporate Officer/Principal | 60 | 20-02-09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 17-12-28 | |
David Scheinberg
BRD | Director/Board Member | 68 | 17-11-30 |
John Varian
BRD | Director/Board Member | 64 | 17-12-28 |
Jane Wasman
CHM | Chairman | 67 | 17-12-28 |
Angelos Stergiou
FOU | Founder | 48 | 06-04-02 |
Katherine Kalin
BRD | Director/Board Member | 61 | 22-08-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 57,754,928 | 57,598,688 ( 99.73 %) | 0 | 99.73 % |
Company contact information
SELLAS Life Sciences Group, Inc.
Times Square Tower 7 Times Square
10026, New York
+
http://www.sellaslifesciences.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.02% | 81.43M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.03% | 21.96B | |
-8.07% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- SLS Stock
- Company SELLAS Life Sciences Group, Inc.